1. Search Result

Search Result

Results for "1226549-49-0" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-128778

    EGFR Cancer
    DBPR112 is an orally active Furanopyrimidine-Based Epidermal Growth Factor Receptor inhibitor with IC50s of 15 nM and 48 nM for EGFR WT and EGFR L858R/T790M, respectively. DBPR112 can occupy the ATP-binding site. DBPR112 has significant antitumor efficacy.